Top

09-07-2018 | Systemic lupus erythematosus | Article

Real-world incidence and prevalence of systemic lupus erythematosus in Alberta, Canada

Journal: Rheumatology International

Authors: Francis Fatoye, Tadesse Gebrye, Lawrence W. Svenson

Publisher: Springer Berlin Heidelberg

Abstract

Systemic lupus erythematosus (SLE) is rather uncommon than rare. The purpose of this study was to estimate the incidence and prevalence of SLE in the population of Alberta, Canada, using administrative health data. Multiple population-based data sources, including the Alberta Health Care Insurance Plan Central Stakeholder Registry (AHCIP CSR), Fee-For-Service, and Hospital Discharge Abstract Database were used. Age- and sex-specific incidence and prevalence rates, and 95% confidence intervals (CI), were computed using the AHCIP CSR mid-year population estimates as the denominator, for the period of 2000–2015. The overall incidence of SLE for all age groups was 4.43 (95% CI 3.65, 5.04) per 100,000 population. The overall incidence in male and female of all age groups was 1.26 (95% CI 0.72, 1.76) and 7.69 (95% CI 6.22, 8.81) per 100,000 population, respectively. A prevalence of 47.99 per 100,000 (male = 13.5, female = 83.2) of SLE was observed for the year 2000 and has increased to 90 (male = 25.5, female = 156.7) per 100,000 population in 2015. Over the 16-year period, the incidence of SLE in women was approximately six times higher than in men (odds ratio = 6.16). The highest and lowest incidence was recorded in 2001 and 2015, respectively. Despite the stable incidence of SLE, the findings of the study confirms that the prevalence of SLE has increased over the 16-year period. The increase in prevalence of SLE in Alberta will have an impact on health service utilizations. This finding can be used for planning and evaluating health services for this group of patients. Further studies are required to determine the economic burden of the condition.

Bernatsky S, Smargiassi A, Barnabe C, Svenson LW, Brand A, Martin RV, Hudson M, Clarke AE, Fortin PR, van Donkelaar A, Edworthy S (2016) Fine particulate air pollution and systemic autoimmune rheumatic disease in two Canadian provinces. Environ Res 146:85–91CrossRefPubMed

Parks CG, Santos ADSE, Barbhaiya M, Costenbader KH (2017) Understanding the role of environmental factors in the development of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 31(3):306–320CrossRefPubMed

Carter EE, Barr SG, Clarke AE (2016) The global burden of SLE: prevalence, health disparities and socioeconomic impact. Nat Rev Rheumatol 12(10):605CrossRefPubMed

Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W (2017) The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology 56(11):1945–1961CrossRefPubMed

McDougall C, Hurd K, Barnabe C (2017) Systematic review of rheumatic disease epidemiology in the indigenous populations of Canada, the United States, Australia, and New Zealand. In: Seminars in arthritis and rheumatism, vol 46, no. 5. Elsevier, New York, pp 675–686

Barnabe C, Joseph L, Belisle P, Labrecque J, Edworthy S, Barr SG, Fritzler M, Svenson LW, Hemmelgarn B, Bernatsky S (2012) Prevalence of systemic lupus erythematosus and systemic sclerosis in the First Nations population of Alberta, Canada. Arthritis Care Res 64(1):138–143CrossRef

Shiff NJ, Lix LM, Joseph L, Duffy C, Tucker LB, Svenson LW, Belisle P, Bernatsky S (2015) The prevalence of systemic autoimmune rheumatic diseases in canadian pediatric populations: administrative database estimates. Rheumatol Int 35(3):569–573CrossRefPubMed

Peschken C, Esdaile J (2000) Systemic lupus erythematosus in North American Indians: a population based study. J Rheumatol 27:1884–1891PubMed

Atkins C, Reuffel L, Roddy J, Platts M, Robinson H, Ward R (1998) Rheumatic disease in the Nuu-Chah-Nulth native Indians of the Pacific Northwest. J Rheumatol 15(4):684–690

10.

Morton RO, Gershwin ME, Brady C, Steinberg AD (1976) The incidence of systemic lupus erythematosus in North American Indians. J Rheumatol 3(2):186–190PubMed

11.

Carriere KC, Roos LL (1994) Comparing standardized rates of events. Am J Epidemiol 140(5):472–482CrossRefPubMed

12.

Johnson AE, Gordon C, Palmer RG, Bacon PA (1995) The prevalence and incidence of systemic lupus erythematosus in Birmingham. Engl Arthritis Rheumatol 38(4):551–558CrossRef

13.

Chakravarty EF, Bush TM, Manzi S, Clarke AE, Ward MM (2007) Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheumatol 56(6):2092–2094CrossRef

14.

Lopez P, Mozo L, Gutierrez C, Suarez A (2003) Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features. Lupus 12(11):860–865CrossRefPubMed

15.

Gudmundsson S, Steinsson K (1990) Systemic lupus erythematosus in Iceland 1975 through 1984. A nationwide epidemiological study in an unselected population. J Rheumatol 17(9):1162–1167PubMed

16.

Reeves WH, Lahita RG (1993) Clinical presentation of systemic lupus erythematosus in the adult. In: Systemic lupus erythematosus, vol 23, 2nd edn. Churchill Livingstone, New York, pp 369–396

17.

Hopkinson ND, Doherty M, Powell RJ (1993) The prevalence and incidence of systemic lupus erythematosus in Nottingham, UK, 1989–1990. Rheumatology 32(2):110–115CrossRef

18.

Jonsson H, Nived O, Sturfelt G, Silman A (1990) Estimating the incidence of systemic lupus erythematosus in a defined population using multiple sources of retrieval. Rheumatology 29(3):185–188CrossRef

Medicine Matters Rheumatology

Abstract